Global Trust Asset Management’s West Pharmaceutical WST Stock Holding History

Global Trust Asset Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,085	Closed	-$299K	–	501
2025 Q4	$299K	Buy	+1,085	New	+$297K	0.12%	116
2022 Q4	–	Sell	-75	Closed	-$18K	–	466
2022 Q3	$18K	Hold	75	–	–	0.01%	289
2022 Q2	$23K	Sell	75 -200	-73%	-$65.1K	0.01%	275
2022 Q1	$113K	Sell	275 -1,325	-83%	-$519K	0.05%	224
2021 Q4	$751K	Sell	1,600 -50	-3%	-$21.5K	0.3%	83
2021 Q3	$701K	Buy	1,650 +700	+74%	+$295K	0.31%	74
2021 Q2	$341K	Buy	+950	New	+$314K	0.16%	127

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Global Trust Asset Management's WST Position: Q1 2026 in Review

Global Trust Asset Management sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 1,085 shares — an estimated $299K sold.

Global Trust Asset Management first reported a position in WST in Q2 2021 and held it in 7 quarters. The position peaked at $751K in Q4 2021. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

Global Trust Asset Management reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
Global Trust Asset Management sold 1,085 West Pharmaceutical shares in Q1 2026, an estimated $299K.
Global Trust Asset Management first reported a position in West Pharmaceutical in Q2 2021 and held it in 7 quarters.
Global Trust Asset Management's West Pharmaceutical position peaked at $751K in Q4 2021.
755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Global Trust Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.